NL-OMON30373尚未招募不适用
Pilot study on the influence of Sutent on tumor vascularization and necrosis in patients with renal cell carcinoma. - Sutent and tumorimaging
niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 5 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- patients with metastatic renal cell cancer for whom treatment with Sutent is planned
- •- measurable primary tumor or metastases (minimal diameter 2 cm) at other sites than the lungs
- •- Karnofsky score equal or larger than 70%
- •- age equal or higher than 18 year.
- •- written informed consent
排除标准
- •- contra-indications for MRI
- •- contra-indications for treatment with Sutentâ
研究者
相似试验
已完成
不适用
Influence of Sutent on Tumor Vascularization and Necrosis in Patients With Renal Cell CarcinomaRenal Cell CancerNCT00509704Radboud University Medical Center10
终止
2 期
Trial of Adjuvant Sutent for Patients With High Risk Urothelial Carcinoma After Neoadjuvant Chemotherapy and CystectomyUrothelial CarcinomaBladder CancerNCT01042795University of Michigan7
进行中（未招募）
2 期
A randomised pilot study to investigate the optimum timing of gemcitabine and concurrent radiation therapy after induction gemcitabine and carboplatin for locally advanced non-small cell lung cancerAdvanced non-small cell lung cancerCancer - Lung - Non small cellACTRN12605000169640Princess Alexandra Hospital24
招募中
2 期
Investigating the effect of a virus-based immunotherapy as a pre-surgical treatment for prostate cancerProstate CancerACTRN12620001286932Royal Melbourne Hospital30
进行中（未招募）
1 期
Selinexor in the treatment of patients with Refractory and/or Relapsed Richter's TransformatioEUCTR2014-001240-38-GBKaryopharm Therapeutics Inc.50